Temasek

Activity from announced rounds

Activity in this selectionEnterprise software

Temasek is a Singapore investment company with global public and private holdings, investing around digitisation, sustainable living, the future of consumption and longer lifespans.

Its global direct investments target both emerging and established market leaders. The four structural themes cut across industries: AI and computing, renewable energy and industrial decarbonisation, changing consumer demand and health-related innovation.

Temasek’s portfolio also includes Singapore-based companies and partnerships with fund managers. Since April 2026, its organisational structure separates global direct investments, Singapore holdings and partnership solutions, giving these distinct investment activities dedicated teams.

Sources
Rounds participated in
9
Confirmed lead rounds
0
7 roles undisclosed
New companies
9
First participation on record · 0 follow-on
Funding in participating rounds
$6.2B
9 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series A2
Series C+2
Seed1
Series B1

By primary sector

AI3
Biotech2
Hardware2
Cybersecurity1
Robotics1

By country

United States5
United Kingdom2
France1
Netherlands1

Rounds

9 in this selection
River AI

Builds infrastructure for training and serving personally trainable AI agents

$1.1BSeed and Series A
Participant
Upscale AI

Provides open-standard AI networking infrastructure for ultra-low-latency training and inference

$190MSeries A+
Role not disclosed
Nearfield Instruments

Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing

$380MSeries D
Role not disclosed
Cyera

Provides a data security and AI governance platform helping enterprises control what AI can see and do

$600MUndisclosed
Role not disclosed
PhysicsX

Builds AI-native engineering simulation software compressing months of design work into seconds for manufacturing and defence

$300MSeries C
Role not disclosed
Isomorphic Labs

Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas

$2.1BSeries B
Role not disclosed
Rhoda AI

Builds robotic intelligence for real-world environments using video-predictive control

$450MSeries A
Role not disclosed
AMI Labs

AMI Labs develops world models that learn representations of sensor data to support prediction, memory and action planning.

$1BSeed
Participant
Insilico Medicine

Develops AI-driven drug discovery and oncology treatments

$5MStrategic
Role not disclosed